http://www.reportbuyer.com/rss.htmlHere you can find business information regarding Vaccines. Reports include data on Europe, UK, USA, Asia and other global markets.en-gbReportbuyerservice@reportbuyer.comenquiries@redwiredesign.comhttp://www.reportbuyer.com/pharma_healthcare/therapeutic/vaccines/china_vaccine_industry_report_2008_2009.htmlIn the past decade, Chinese vaccine market tripled in scale. China has already become the world's largest vaccine producer and now has 28 vaccine companies, ranking NO. 1 around the globe. 0ac5b788360d501fa13c282a02a406f1Sat, 08 Aug 2009 12:00:00 GBTherapeutic/Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/vaccines/analyzing_edible_vaccines.htmlThe research report Analyzing Edible Vaccines by Aruvian Research details the revolutionary strides in the field of vaccine industry which is crucial in the human fight against diseases which were earlier only countered with traditional vaccination programs.  The essence of this approach is to ensure specificity of application, precision of targeting and achieving results comparably sustained with the traditional vaccination programs. Since studies have shown the best acceptance by humans to vaccination programs which are virtually “invisible” this school of thought has resulted in the introduction of a revolution known as “edible vaccines”. 0a58a1375a4a91d06dc97421a0240e56Wed, 01 Jul 2009 12:00:00 GBTherapeutic/Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/vaccines/global_vaccine_market_forecast_2012.htmlVaccines have emerged as one of the most lucrative segment in the global pharmaceutical industry. With a projected CAGR of over 13% during 2009-2012, the industry will emerge as the fastest growing therapy area. The US and Europe represent the two largest vaccine markets in the world and will continue experiencing healthy growth rate in future. 0a7458781f889d3e41db27115b2d3e27Sat, 06 Jun 2009 12:00:00 GBTherapeutic/Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/vaccines/world_vaccines_market_2008_2013.htmlWorld Vaccines Market 2008-2013: Future Forecast, Critical Trends and Developments published by Renub Research talks about the world vaccine market. This report gives the past, present scenario on the vaccines market and also forecast on future of vaccines market. Such as market size of Hepatitis B vaccines, Pneumococcal vaccines, Cervical Cancer vaccines etc. c37b13ce1e44e2585be023fb224682bbTue, 14 Apr 2009 12:00:00 GBTherapeutic/Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/vaccines/research_report_vaccine_industry.htmlVaccine is an active immunity product composed of particular bacteria, virus, rickettsia, spirochete, mycoplasma, and parasite. As one of the six key points of medicine development, vaccine area will become one of the industry that most attracting attention in this century. This report is to analyze the development trend and relative policy environment of the vaccine market, and focus on the research in the priced vaccine market scale, manufacturing enterprise and demand. 8d0566d8df2ecd6f29f050bc9186e721Sat, 04 Apr 2009 12:00:00 GBTherapeutic/Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/vaccines/research_report_chinese_bird_flu_vaccine_industry_2009.htmlZoonosis refers to a kind of infectious disease that plagues between animals and human beings. Some plagues, though discovered, spread widely all over the world. Others are newly found, such as the swine flu. c201e8b88c3b057d1d72ff1605f11e1fSat, 04 Apr 2009 12:00:00 GBTherapeutic/Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/vaccines/scientiavision_product_pinpoint_new_vaccines.htmlVaccines approved in the last five years have not only improved on previous products, but have created entirely new markets addressing patients of all ages.   Merck's RotaTeq and GlaxoSmithKline's Rotarix rotavirus vaccines are intended for infants, Merck's Gardasil and GlaxoSmithKline's Cervarix (not yet approved in the United States) human papillomavirus (HPV) vaccines are intended for female patients aged 9 to 26, GlaxoSmithKline's Twinrix provides protection against both hepatitis A and hepatitis B for patients aged 18 and over, and Merck's Zostavax prevents herpes zoster (shingles) in patients aged 60 and over.  Vaccines in new therapeutic areas have created entirely new market segments and expanded the target population for vaccines. f48c46365651ddf788c650216d1b8aa5Tue, 31 Mar 2009 12:00:00 GBTherapeutic/Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/vaccines/research_report_chinas_foot_and_mouth_disease_vaccine_fmd_vaccine_industry_2009.htmlFoot and mouth disease was the first animal virus people recognized. People had struggled with it for more than one hundred years. Besides several countries with natural quarantine conditions, foot and mouth disease still out broke and spread in many countries. 9509082e020f75c20c79587442556f81Tue, 03 Mar 2009 12:00:00 GBTherapeutic/Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/vaccines/research_report_chinas_animal_vaccine_industry_2009.htmlIn 2008, the market size of Chinese animal vaccine is about 3 billion Yuan (0. 43 billion US Dollars), increased by 30% in 2007, and will still keep a fast growth in years. This depends on many factors: first, the food consumption of Chinese residents has changed from quantity to quality. 8d849ea7b92c4c4b4bed12668104e278Tue, 03 Mar 2009 12:00:00 GBTherapeutic/Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/vaccines/freedonia_focus_vaccines.htmlThis report discusses US vaccines for the years 2003 and 2008, with forecasts for 2013. Topics covered include market size, product segmentation, global human vaccine immunization rates, trade, technological and product development, regulatory considerations, market environment, product forecasts, industry composition and leading participants. Product segments include human vaccines and animal vaccines. 04f748d0c18e564ff5f86e3dcb6e9886Mon, 02 Feb 2009 12:00:00 GBTherapeutic/Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/vaccines/analytical_tool_vaccines.html"Analytical Tool - Cancer Vaccines" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in cancer vaccine drug development. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. 000a5331abc8dc373626e18aa614ed1bThu, 01 Jan 2009 12:00:00 GBTherapeutic/Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/vaccines/emerging_cancer_vaccines_market_forecasts_new_developments_pipeline_analysis.htmlIt is the general consensus of scientists that cancer vaccines will become a reality. Overall the cancer treatment market continues to grow and this demand sets the stage for vaccine products. Several promising vaccines: the propholactic Gardasil has created a pathway for new vaccine products. 50f2785ab104f111812607d55023c62eTue, 11 Nov 2008 12:00:00 GBTherapeutic/Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/vaccines/immunotherapies_vaccines_cancer_infectious_diseases.htmlThe field of therapeutic vaccines and immunotherapies is rapidly emerging as a promising area. Use of passive immunotherapy (i. e. 7027ef8ab5dab713c22693d909cb0611Fri, 10 Oct 2008 12:00:00 GBTherapeutic/Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/vaccines/european_vaccines_market.htmlThe European Vaccines market discusses and analyses the evolving market scenario. The research service provides revenue estimation and forecast based on the factors that are expected drive and restrain the market in the forecast period. Challenges faced by the industry are analysed and strategic recommendations are discussed based on the current and future trends in the European Market. f8d01c4fac2fb0a7a941c21725f0eea3Tue, 09 Sep 2008 12:00:00 GBTherapeutic/Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/vaccines/global_vaccines_market_2008_2023_1.htmlThe period 2008-2023 will see a vaccine "boost". There will be a new resurgence in the sales and utilisation of vaccines. Are you prepared for this? You should be. 1b14ba9298a99367ea2f36d35d6be730Fri, 08 Aug 2008 12:00:00 GBTherapeutic/Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/vaccines/china_vaccine_market_report_2007_2009.htmlChina is the largest vaccine producer and consumer in the world. According to the statistics of the General Administration of Customs, China's total vaccine import and export volume reached 34,846 tons in the first five months of 2008, of which 7,735 tons were imports, and 27,111 tons were exports. China's total vaccine import and export value in the same period was US$217. 24485b5738b31f4cc44e1160891a6b8fMon, 07 Jul 2008 12:00:00 GBTherapeutic/Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/vaccines/human_vaccines.htmlThis report analyzes the worldwide markets for Human Vaccines in Millions of US$. The major product segments analyzed are Prophylactic Vaccines (Pediatric Prophylactic Vaccines, & Adult Prophylactic Vaccines), and Therapeutic Vaccines. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East and Latin America. 4f60d51b4c951415e842bf9b553805aeMon, 05 May 2008 12:00:00 GBTherapeutic/Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/vaccines/pipeline_insight_nosocomial_vaccines.html As the reimbursement status for the cost of hospital-acquired infections is under pressure by payors, interest in preventing these complications at the outset is growing. Nosocomial vaccines offer one route of prevention. This report assesses the clinical pipeline candidates five key nosocomial pathogens and their potential market environment including target population size estimates. e37bbab4ea4cb077d1f58f99a87b7d7cThu, 17 Apr 2008 12:00:00 GBTherapeutic/Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/vaccines/vaccines.htmlVaccine manufacturers from all over the world have been involved in a stalemate with governments regarding supply and demand. While governments are reluctant to ensure steady demand for vaccines unless the manufacturers can prove their ability to increase their supply, the latter are apprehensive about increasing production without a guarantee of sustained demand from the governments. Meanwhile, developing nations are increasingly demanding vaccines that are no longer included in the immunization schedules of developed countries. 4e4f5136f7de7de5e4c2ad9546a51bf8Sat, 01 Mar 2008 12:00:00 GBTherapeutic/Vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/vaccines/strategic_analysis_south_african_paediatric_vaccines_markets.htmlResearch was carried out on the healthcare industry of South Africa. A thorough PESTLE (political, economic, social, technology, legal and environmental) analysis was established for South Africa allowing for an accurate evaluation of the external factors impacting on the healthcare industry. Market size of the paediatric vaccine sector was calculated for 2006 and forecasts determined for the period 2006 to 2012. 52f36ccb5cd83c428ea1f96b2481de37Sat, 02 Feb 2008 12:00:00 GBTherapeutic/Vaccines